Search

everythinglearnresearchcommunity

for

Search:↓

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Ashwagandha root improved symptoms of nonclassic 11-hydroxylase deficiency in an elderly woman.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

H. pylori infection is not linked to PCOS or infertility.

Trichoscopy helps diagnose and manage different types of hair loss in the Indian population.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Mesenchymal stem cells show promise for effective skin repair and regeneration.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

People with polycystic ovary syndrome often have low levels of vitamin D.

The combination therapy is safe and effective for treating Female Pattern Hair Loss in Asian women.

Targeting the Smoothened receptor shows promise for treating certain cancers.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Women inventors focus more on women's health, but there are few of them.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

The compounds tested could potentially treat hair loss and alopecia.

ADSC-derived extracellular vesicles show promise for skin and hair regeneration and wound healing.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.

Plum blossom needle acupuncture with qi-invigorating therapy is more effective for Seborrheic Alopecia than Western medicine.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.